The Cambridge-based pharmaceutical development company, Nuformix, were in the studio today to discuss their innovative cocrystal technology and their recent round of fundraising which brought in £1.3 million.
The Cambridge-based pharmaceutical development company, Nuformix, were in the studio today to discuss their innovative cocrystal technology and their recent round of fundraising which brought in £1.3 million.